We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abionyx Pharma | EU:ABNX | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.006 | 0.59% | 1.024 | 1.00 | 1.024 | 1.03 | 1.00 | 1.02 | 25,009 | 16:35:24 |
From Apr 2022 to Apr 2024
Regulatory News:
ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announces its financial agenda for 2023.
Events
Date*
Cash position and activity update for Q4 2022
Tuesday, February 28, 2023
2022 Full-Year Results
Thursday, April 27, 2023
Cash position and activity update for Q1 2023
Wednesday, May 17, 2023
Cash position and activity update for Q2 2023
Thursday, August 17, 2023
2023 Half-Year Results
Thursday, September 28, 2023
Cash position and activity update for Q3 2023
Thursday, November 16, 2023
* indicative dates subject to change
About ABIONYX Pharma
ABIONYX Pharma is a new generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones. Thanks to its partners in research, medicine, biopharmaceuticals and shareholding, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230112005910/en/
NewCap Investor relations Louis-Victor Delouvrier Nicolas Fossiez abionyx@newcap.eu +33 (0)1 44 71 98 53
NewCap Media relations Arthur Rouillé abionyx@newcap.eu +33 (0)1 44 71 94 94
1 Year Abionyx Pharma Chart |
1 Month Abionyx Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
